United States · FDA National Drug Code directory
Hydralazine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-0139_d14a312f-cf30-4282-8387-ac085046255b
- Product NDC
- 50090-0139
- Form
- TABLET
- Composition / generic term
- Hydralazine Hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100101
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDRALAZINE HYDROCHLORIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (50090-0139-1) · 50090-0139-1
- 180 TABLET in 1 BOTTLE (50090-0139-2) · 50090-0139-2
- 90 TABLET in 1 BOTTLE (50090-0139-3) · 50090-0139-3
- 270 TABLET in 1 BOTTLE (50090-0139-4) · 50090-0139-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →